Literature DB >> 24243803

Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?

Michael S Okun1, Daniel Weintraub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24243803      PMCID： PMC3859686          DOI： 10.1002/mds.25735

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  48 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

2.  Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction.

Authors:  J Kuhn; M Möller; J F Treppmann; C Bartsch; D Lenartz; T O J Gruendler; M Maarouf; A Brosig; U B Barnikol; J Klosterkötter; V Sturm
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

Review 3.  Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review.

Authors:  P Shotbolt; J Moriarty; A Costello; A Jha; A David; K Ashkan; M Samuel
Journal:  Parkinsonism Relat Disord       Date:  2011-09-14       Impact factor: 4.891

4.  Binge eating in Parkinson's disease: prevalence, correlates and the contribution of deep brain stimulation.

Authors:  Laura B Zahodne; Frandy Susatia; Dawn Bowers; Tiara L Ong; Charles E Jacobson; Michael S Okun; Ramon L Rodriguez; Irene A Malaty; Kelly D Foote; Hubert H Fernandez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

5.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Authors:  Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

6.  Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers.

Authors:  David Okai; Sally Askey-Jones; Michael Samuel; Sean S O'Sullivan; K Ray Chaudhuri; Anne Martin; Joel Mack; Richard G Brown; Anthony S David
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

7.  Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

Authors:  Alexandre Eusebio; Tatiana Witjas; Julien Cohen; Frédérique Fluchère; Elisabeth Jouve; Jean Régis; Jean-Philippe Azulay
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-02-27       Impact factor: 10.154

Review 8.  [Deep brain stimulation in the context of addiction--a literature-based systematic evaluation].

Authors:  R Bauer; S Pohl; J Klosterkötter; J Kuhn
Journal:  Fortschr Neurol Psychiatr       Date:  2008-07       Impact factor: 0.752

Review 9.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  Andrew H Evans; Antonio P Strafella; Daniel Weintraub; Mark Stacy
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

10.  Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects.

Authors:  Polyvios Demetriades; Hugh Rickards; Andrea Eugenio Cavanna
Journal:  Parkinsons Dis       Date:  2011-02-20
View more
  11 in total

Review 1.  Sleep in Parkinson's Disease with Impulse Control Disorder.

Authors:  Michela Figorilli; Patrizia Congiu; Rosa Lecca; Gioia Gioi; Roberto Frau; Monica Puligheddu
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-11       Impact factor: 5.081

Review 2.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

3.  Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy.

Authors:  P Justin Rossi; Sol De Jesus; Christopher W Hess; Daniel Martinez-Ramirez; Kelly D Foote; Aysegul Gunduz; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2017-08-09       Impact factor: 4.891

Review 4.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

Review 5.  Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.

Authors:  Michael Samuel; Maria Rodriguez-Oroz; Angelo Antonini; Jonathan M Brotchie; Kallol Ray Chaudhuri; Richard G Brown; Wendy R Galpern; Melissa J Nirenberg; Michael S Okun; Anthony E Lang
Journal:  Mov Disord       Date:  2015-01-21       Impact factor: 10.338

6.  STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Authors:  Nolan R Williams; Kelly D Foote; Michael S Okun
Journal:  Mov Disord Clin Pract       Date:  2014-04-01

Review 7.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

8.  Advanced Therapies for the Management of Dopamine Dysregulation Syndrome in Parkinson's Disease.

Authors:  Sanskriti Sasikumar; Roberto Matta; Renato P Munhoz; Mateusz Zurowski; Yu-Yan Poon; Mojgan Hodaie; Suneil K Kalia; Andres M Lozano; Alfonso Fasano
Journal:  Mov Disord Clin Pract       Date:  2021-03-11

Review 9.  Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update.

Authors:  Jee-Young Lee; Beom Seok Jeon
Journal:  J Mov Disord       Date:  2014-10-30

10.  Update on deep brain stimulation in Parkinson's disease.

Authors:  Daniel Martinez-Ramirez; Wei Hu; Alberto R Bona; Michael S Okun; Aparna Wagle Shukla
Journal:  Transl Neurodegener       Date:  2015-06-27       Impact factor: 8.014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.